The biotech stock index, which rose early in the pandemic on hopes for Covid-19 treatments, has fallen amid research failures, slowing M&A and rising interest rates
Scientists are using automation, real-time analysis and pooling data from around the world to rapidly identify and understand new coronavirus variants before the next one spreads widely. Photo Illustration: Sharon ShiBiotech companies are having one of their worst stock-market runs in years, as rising interest rates, scientific setbacks and a slowdown in big pharma buyouts batter the sector.
Biotech stocks began soaring in the spring of 2020 as individual investors and hedge funds flocked to the sector amid intense attention on the race to develop new vaccines and . The uptick in demand for biotech stocks helped fuel a historic boom in initial public offerings and venture-capital investment into 2021.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
La source: latimes - 🏆 11. / 82 Lire la suite »
La source: MarketWatch - 🏆 3. / 97 Lire la suite »
La source: TucsonStar - 🏆 339. / 59 Lire la suite »
Sports Fanatics Should Consider Buying These Three Stocks, Jim Cramer Says“You’ve got a lot of options if you want to own part of a pro-sports team or even a whole league, but they’re not always the best stocks,” Cramer said. Hmm.. what stocks should people who want to make money buy? Buy those stocks if you don’t want to make money. The Cramer Curse is real.
La source: nbcchicago - 🏆 545. / 51 Lire la suite »
La source: FoxBusiness - 🏆 458. / 53 Lire la suite »
La source: MarketWatch - 🏆 3. / 97 Lire la suite »